ONCUSP THERAPEUTICS
OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments. It is always working to improve the largest value inflection point in the drug development value chain, believing that speeding oncology medication innovation is the most effective method to provide help and hope to cancer patients around the world. It is founded by Bing Yuan, Eric Slosberg, and Andy Fu.
ONCUSP THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Product Research
Website Url:
http://www.oncusptx.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible
Similar Organizations
Allovate Therapeutics
Allovate Therapeutics is a biopharmaceutical company dedicated to making allergy treatment easier.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Duopharma Biotech
Duopharma Biotech is pharmaceutical company in Malaysia that provides quality and innovative solutions.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Gankill Pharmaceutical
Gankill Pharma Co., Ltd. is conducting research on cancer treatment drugs using PSMD10.
Harm Reduction Therapeutics
Harm Reduction Therapeutics is a nonprofit pharmaceutical company advancing harm reduction therapies to promote public health.
iuvo Therapeutics
iuvo Therapeutics is a pharmaceutical company focused on providing a portfolio of medical cannabis products for European patients.
Kupando
Kupando is a biopharmaceutical company that develops agonists to stimulates innate immunity.
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
Rx-Pharma
Rx Pharma is a Pharmaceutical marketing research and regulatory affairs consultancy based in Ghana.
Spinotech
Spinotech offers the biotechnology, pharmaceutical, and medical technology industries with solutions to increase online visibility.
SuperNemos
SuperNemos is a biological control product containing microscopic beneficial nematodes.
Uteron Pharma
At Uteron pharma they are committed to enabling (cutting-edge scientific) research that is driven by the womenโs needs.
Current Employees Featured
Founder
Official Site Inspections
http://www.oncusptx.com
- Host name: 104.26.1.56
- IP address: 104.26.1.56
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "OnCusp Therapeutics"
About Us-OnCusp Therapeutics
Prior to that, Ms. Marreddy served as Head of Clinical Operations at Rafael Pharmaceuticals (now Cornerstone Pharmaceuticals) where she built and led the Clinical Operations organization in โฆSee details»
OnCusp Therapeutics
Jun 13, 2024 OnCusp Therapeutics is a global biopharmaceutical company translating a focused portfolio of first-in-class oncology assets from promising research into proven medicines. The โฆSee details»
OnCusp Therapeutics - Crunchbase Company Profile
OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments. It is always working to โฆSee details»
R&D-OnCusp Therapeutics
CUSP06, a CDH6 ADC, is composed of a proprietary antibody with high CDH6 binding affinity, a protease-cleavable linker, and an exatecan payload (a potent and clinically validated โฆSee details»
OnCusp Therapeutics - LinkedIn
Oncusptx.com 50 3 Comments Like Comment Share OnCusp Therapeutics 2,021 followers 3mo Report this post We are thrilled to be named a member of BioSpace NextGen Class of 2025, the top life science ...See details»
Amy Penticoff - OnCusp Therapeutics - LinkedIn
Lake N. Paul, PhD. is in San Diego at the Biotechnology Innovation Organization #BIO2024 conference meeting with colleagues & future clients. Connect with him in person to learn about โฆSee details»
OnCusp Therapeutics - Drug pipelines, Patents, Clinical trials
Www.oncusptx.com. Startups | Holding Company | 2021 | New York, United States | 10-50 | www.oncusptx.com. Last update 07 Mar 2025. Overview. Pipeline. Deal. Translational โฆSee details»
Newsroom-OnCusp Therapeutics
Mar 06, 2024. OnCusp Therapeutics Announces First Patient Dosed in Phase 1 Trial of CUSP06 in Patients with Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid โฆSee details»
Company News-OnCusp Therapeutics
Jan 04, 2024. OnCusp Therapeutics Raises Oversubscribed $100 Million Series A Financing to Advance Portfolio of Assets for Cancer Patients. Learn moreSee details»
OnCusp Therapeutics - VentureRadar
Website: https://www.oncusptx.com/ Develops innovative preclinical ideas into clinically validated treatments for cancer patients, notably CUSP06, a promising ADC ...See details»
OnCusp Therapeutics - Craft
OnCusp Therapeutics is a biopharmaceutical company that specializes in cancer treatment solutions. It focuses on developing bispecific antibodies, antibody-drug conjugates, and small โฆSee details»
OnCusp Therapeutics Commences Operations to Advance โฆ
Jun 30, 2021 The World Health Organization (WHO) released its latest estimates showing that the global cancer burden has risen to 19.3 million new cases and 10.0 million deaths in 2020, โฆSee details»
OnCusp - Overview, News & Similar companies | ZoomInfo.com
Jan 3, 2024 OnCusp contact info: Phone number: (646) 585-2168 Website: www.oncusptx.com What does OnCusp do? OnCusp Therapeutics is a global biopharmaceutical company โฆSee details»
OnCusp Therapeutics Commences Operations to Advance โฆ
The World Health Organization (WHO) released its latest estimates showing that the global cancer burden has risen to 19.3 million new cases and 10.0 million deaths in 2020, with one in โฆSee details»
OnCusp Therapeutics Showcases Potent Anti-Tumor Activity of ... - BioSpace
SHENZHEN, China, April 11, 2023 /PRNewswire/ -- OnCusp Therapeutics, a global biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer patients worldwide, today announced that the preclinical data on its lead program CUSP06 will be presented during the American Association for โฆSee details»
OnCusp Therapeutics - VentureRadar
Website: https://www.oncusptx.com/ Develops oncology therapeutics through deep translational and clinical expertise, aiming to reach clinical proof of concept and ...See details»
OnCusp Therapeutics Commences Operations to Advance
The World Health Organization (WHO) released its latest estimates showing that the global cancer burden has risen to 19.3 million new cases and 10.0 million deaths in 2020, with one in โฆSee details»
OnCusp-ๅจ่็ฝ - vbdata.cn
Apr 1, 2022 OnCusp Therapeutics ๆฏไธๅฎถ่ดๅไบๅฐๅฐ็ซฏ่ฟ็คๅๆฒฟ่ฏ็ฉ่ฝฌๅไธบๅๆฐ็ๆณ็ๅ จ็็็ฉๅถ่ฏๅ ฌๅธใๅ ฌๅธ็ฑๅจไธดๅบ่ฝฌๅใๅๅกๆๅฑไปฅๅ็ปๅปบๅ็ฎก็ๅๅ็็ฉๅถ่ฏไผไธๆน้ขๅ ทๆไธฐๅฏ็ป้ช โฆSee details»
Careers-OnCusp Therapeutics
Headquartered in Princeton, OnCusp Therapeutics is transforming a growing portfolio of leading-edge molecules on the cusp of becoming innovative treatments to deliver hope to patients โฆSee details»
OnCusp Therapeutics Commences Operations to Advance โฆ
Apr 1, 2021 NEW YORK, June 29, 2021 /PRNewswire/ -- OnCusp Therapeutics Commences Operations to Advance Innovative Oncology TherapiesSee details»